Ligand validation:4R7J

IMP: INOSINIC ACID

IMP is a Ligand Of Interest in 4R7J designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4R7J_IMP_A_500	81%	30%	0.121	0.975	1.45	1.35	2	5	0	0	100%	1
5UQG_IMP_C_500	94%	30%	0.086	0.984	1.36	1.43	2	4	1	0	100%	1
5UQH_IMP_D_503	91%	31%	0.098	0.983	1.43	1.33	2	4	0	0	100%	1
4MZ1_IMP_A_500	87%	31%	0.105	0.978	1.43	1.32	2	4	1	0	100%	1
4MZ8_IMP_C_501	80%	33%	0.125	0.973	1.4	1.24	2	4	3	0	100%	1
5URQ_IMP_B_500	76%	26%	0.142	0.979	1.42	1.55	2	4	2	0	100%	1
8QWA_IMP_A_501	100%	47%	0.038	0.987	1.01	1.04	3	3	0	0	100%	1
9C4M_IMP_G_801	99%	55%	0.051	0.982	0.94	0.79	1	-	0	0	100%	1
4FXS_IMP_A_701	98%	17%	0.056	0.98	1.71	1.89	4	7	1	0	100%	1
5UWX_IMP_C_501	98%	33%	0.06	0.984	1.3	1.35	3	2	2	0	100%	1
2C6Q_IMP_E_1337	98%	19%	0.06	0.984	1.94	1.53	5	6	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.